From the Issue
Ultra-Rare Cancers: Opening Doors to Therapeutic Discovery
Rare cancers once were the forgotten cousins of diseases known to impact larger populations. Fortunately, medical thinking has evolved, and the way rare diseases are considered is rapidly changing.
Options Emerge for Relapsed/Refractory Hodgkin Lymphoma
Multiple options are emerging for the treatment of third-line Hodgkin lymphoma (HL), including repurposed drugs, HL-specific drugs, and CAR T-cell therapy.
Rare Blood Cancers in 2018 & Beyond
A surprisingly high number of scientific observations and discoveries in the hematology/oncology world have in fact been made in more rare disease entities first, then studied, and upon further investigation, subsequently applied to more common tumor types.
Read More Research Highlights
Are you looking for the latest hematology/oncology research? Check out additional highlights featuring the cutting-edge discoveries in the field.
Looking for resources to share with your colleagues and patients? Check out patient handouts on a variety of topics, including “Maximizing Resilience,” which encourages patients to think about resilience in new ways and take steps to building this quality.